KCG
IBIO icon

Knight Capital Group’s iBio IBIO Stock Holding History

Knight Capital Group’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$5K Buy
+2
New +$4.61K ﹤0.01% 3232

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Knight Capital Group's IBIO Position: Q2 2013 in Review

Knight Capital Group opened a new position in iBio (IBIO) in Q2 2013: 2 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #3232 among its holdings.

10 funds tracked by Wall St. Rank hold IBIO as of Q2 2013.

  • Knight Capital Group held 2 shares of iBio worth $5K as of Q2 2013.
  • iBio was a new Knight Capital Group position in Q2 2013.
  • iBio made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3232 holding.
  • 10 funds tracked by Wall St. Rank held iBio as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.